A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants
Clinical trial NCT03758339 · COMPLETED
Trial details
- NCT number
- NCT03758339
- Sponsor
- Cascadian Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-30
- Primary completion
- 2018-01-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.